Kobayashi Pharmaceutical Co's total assets for Q4 2024 were ¥265.37B, an increase of 5.94% from the previous quarter. KBYPF total liabilities were ¥51.90B for the fiscal quarter, a 13.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.